In experimental models of PD, such as 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenylpyridinium ion (MPP+), and ROT, attenuation of mTOR signaling and downstream signaling of p70s6 kinase inactivation have been reported [16]. This evidence concerns the gene MTOR and Parkinson disease.